Positioning Biologic Therapies in the Management of Pediatric Inflammatory Bowel Disease

Clicks: 125
ID: 266776
2020
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #2 of 2 articles by views in gastroenterology & hepatology

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
The incidence and prevalence of pediatric inflammatory bowel disease (IBD) are rising worldwide, with a steep increase in children under 5 years of age. Compared to adult IBD, pediatric IBD presents with a more severe, aggressive phenotype and unique complications, notably growth impairment. Treatme …
Reference Key
j2020gastroenterologypositioning Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Breton J;Kastl A;Conrad MA;Baldassano RN;;
Journal gastroenterology & hepatology
Year 2020
DOI
DOI not found
URL
https://www.pubmed.gov/34035746/
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE pubmed abstract nih national institutes of health national library of medicine pmid:34035746 pmc8132662 jessica breton arthur kastl robert n baldassano

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.